SAN FRANCISCO--(BUSINESS WIRE)--Osteologix Inc. (OTCBB:OLGX - News), a specialty pharmaceutical company, today announced that Malene Weis M.SC.Pharm., Director of Clinical Development of Osteologix, will give a presentation entitled “Challenges for Small Pharma in Setting up and Managing a Clinical Trial” during a Symposium regarding outsourcing challenges for small pharma and biotech at the 6th Annual Partnerships in Clinical Trials Congress and Exhibition 2007 on Monday, November 5, 2007 in Amsterdam RAI, The Netherlands. Following her presentation, Weis will participate as a panel member during the Discussion Session entitled “Developing an Outsourcing Strategy that Keeps Pace with Your Company’s Growth”. Weis has worked with all stages of clinical development at both pharmaceutical companies and contract research organizations (CROs). She has held prime responsibility for the design and operational execution of numerous clinical trials within various therapeutic areas, including Osteologix’s latest Phase II STRONG Study of the company’s lead drug candidate for the treatment and prevention of osteoporosis, NB S101. The data for the STRONG Study will be released in the 4th quarter of 2007.
